HMG-CoA reductase inhibitor lovastatin upregulates plasminogen activator production through RhoA-signaling in peritoneal cell line Met5A

Gynecological Surgery

Volumn 7, Issue 2, 2010, Pages 189-193

  Suzuki, Noriko ^a   Imai, Atsushi ^b  

^a GIFU UNIVERSITY   (Japan)

^b Matsunami General Hospital   (Japan)

Author keywords

Peritoneal cells; Postoperative adhesion; RhoA; Statin; Tissue type plasminogen activator

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVINOLIN; PLASMINOGEN ACTIVATOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CELL STRAIN; CELL STRAIN MET5A; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; FIBRINOLYSIS; HUMAN; HUMAN CELL; PERITONEUM CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURGICAL PATIENT; UPREGULATION;

EID: 77952283936     PISSN: 16132076     EISSN: 16132084     Source Type: Journal    
DOI: 10.1007/s10397-009-0546-7     Document Type: Article

References (15)

1. DiZeregal G, Campeau J (2001) Peritoneal repair and postsurgical adhesion formation. Hum Reprod Update 7:547-555
2. González-Quintero V, Cruz-Pachano F (2009) Preventing adhesions in obstetric and gynecologic surgical procedures. Rev Obstet Gynecol 2:38-45
3. Aarons C, Cohen P, Gower A, Reed K, Leeman S, Stucchi A, Becker J (2007) Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg 245:176-184
4. Sulaiman H, Dawson L, Laurent G, Bellingan G, Herrick S (2002) Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Transact 30:126-131
5. Endres M, Laufs U (2004) Effects of statins on endothelium and signaling mechanisms. Stroke 35:2708-2711
6. Fritz G (2005) HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). Int J Oncol 27:1401-1409
7. Liao J, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89-118
8. Agarwal B, Halmos B, Feoktistov A, Protiva P, Ramey W, Chen M, Pothoulakis C, Lamont J, Holt P (2002) Mechanism of lovastatininduced apoptosis in intestinal epithelial cells. Carcinogenesis 23:521-528 (Pubitemid 34257633)
9. Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C (2008) HMGCoA reductase inhibitor simvastatin overcomes bortezomibinduced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway. Biochem Biophys Res Commun 374:309-314
10. Haslinger B, Goedde M, Toet K, Kooistra T (2002) Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Kidney Int 62:1611-1619
11. Haslinger B, Kleemann R, Toet K, Kooistra T (2003) Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int 63:2065-2074
12. KeyomarsiK, Sandoval L, BandV, PardeeA (1991) Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 51:3602-3609
13. Narumiya S, Tanji M, Ishizaki T (2009) Rho signaling, rock and mdia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 28:65-76
14. Farina H, Bublik D, Alonso D, Gomez D (2002) Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells. Clin Exp Metastasis 19:51-559
15. Van der Wal J, Jeekel J (2007) The use of statins in postoperative adhesion prevention. Ann Surg 245:185-186